Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 46, 2017 - Issue 6
175
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Association of IL-10-Regulating MicroRNAs in Peripheral Blood Mononuclear Cells with the Pathogenesis of Autoimmune Thyroid Disease

, , , , , , , & ORCID Icon show all

References

  • Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol, 8, 942–949.
  • Balasa B, Sarvetnick N. 1998. Cytokines and IDDM: Implications for etiology and therapy. Drug News Perspect, 11, 356–360.
  • Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 116, 281–297.
  • Brent GA. 2010. Environmental exposures and autoimmune thyroid disease. Thyroid, 20, 755–761. doi: 10.1089/thy.2010.1636
  • Carlsen AL, Schetter AJ, Nielsen CT, et al. 2013. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum, 65, 1324–1334. doi: 10.1002/art.37890
  • Ceribelli A, Satoh M, Chan EK. 2012. MicroRNAs and autoimmunity. Curr Opin Immunol, 24, 686–691. doi: 10.1016/j.coi.2012.07.011
  • Couper KN, Blount DG, Riley EM. 2008. IL-10: The master regulator of immunity to infection. J Immunol, 180, 5771–5777.
  • Friedman RC, Farh KK, Burge CB, Bartel DP. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res, 19, 92–105.
  • Haneklaus M, Gerlic M, O’Neill LA, Masters SL. 2013. miR-223: Infection, inflammation and cancer. J Intern Med, 274, 215–226. doi: 10.1111/joim.12099
  • Hayashi F, Watanabe M, Nanba T, et al. 2009. Association of the −31C/T functional polymorphism in the interleukin-1beta gene with the intractability of Graves’ disease and the proportion of T helper type 17 cells. Clin Exp Immunol, 158, 281–286.
  • Honardoost MA, Naghavian R, Ahmadinejad F, et al. 2015. Integrative computational mRNA-miRNA interaction analyses of the autoimmune-deregulated miRNAs and well-known Th17 differentiation regulators: An attempt to discover new potential miRNAs involved in Th17 differentiation. Gene, 572, 153–162. doi: 10.1016/j.gene.2015.08.043
  • Inoue N, Watanabe M, Wada M, et al. 2013. IL-10-592A/C polymorphism is associated with severity of Hashimoto’s disease. Cytokine, 64, 370–374. doi: 10.1016/j.cyto.2013.05.014
  • Inoue Y, Watanabe M, Inoue N, et al. 2014. Associations of single nucleotide polymorphisms in precursor-microRNA (miR)-125a and the expression of mature miR-125a with the development and prognosis of autoimmune thyroid diseases. Clin Exp Immunol, 178, 229–235. doi: 10.1111/cei.12410
  • Jacobson EM, Tomer Y. 2007. The genetic basis of thyroid autoimmunity. Thyroid, 17, 949–961.
  • Kagawa T, Watanabe M, Inoue N, et al. 2016. Increases of microRNA let-7e in peripheral blood mononuclear cells in Hashimoto’s disease. Endocr J, 63, 375–380. doi: 10.1507/endocrj.EJ15-0577
  • Liu R, Ma X, Xu L, et al. 2012. Differential microRNA expression in peripheral blood mononuclear cells from Graves’ disease patients. J Clin Endocrinol Metab, 97, E968–72. doi: 10.1210/jc.2011-2982
  • Liu Y, Chen Q, Song Y, et al. 2011. MicroRNA-98 negatively regulates IL-10 production and endotoxin tolerance in macrophages after LPS stimulation. FEBS Lett, 585, 1963–1968. doi: 10.1016/j.febslet.2011.05.029
  • Lu MC, Yu CL, Chen HC, et al. 2014. Increased miR-223 expression in T cells from patients with rheumatoid arthritis leads to decreased insulin-like growth factor-1-mediated interleukin-10 production. Clin Exp Immunol, 177, 641–651. doi: 10.1111/cei.12374
  • Menconi F, Oppenheim YL, Tomer Y. 2008. Graves’ disease. In Diagnostic Criteria in Autoimmune Diseases, edited by Cervera R, Shoenfeld Y, Me G, 231–235. Totowa, NJ: Humana Press.
  • Moore KW, De Waal Malefyt R, Coffman RL, O’Garra A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol, 19, 683–765.
  • Nanba T, Watanabe M, Inoue N, Iwatani Y. 2009. Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ disease. Thyroid, 19, 495–501.
  • Paraskevi A, Theodoropoulos G, Papaconstantinou I, et al. 2012. Circulating microRNA in inflammatory bowel disease. J Crohns Colitis, 6, 900–904. doi: 10.1016/j.crohns.2012.02.006
  • Pauley KM, Cha S, Chan EK. 2009. MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun, 32, 189–194.
  • Roncarolo MG, Bacchetta R, Bordignon C, et al. 2001. Type 1 T regulatory cells. Immunol Rev, 182, 68–79.
  • Saunders MA, Liang H, Li WH. 2007. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA, 104, 3300–3305.
  • Sharma A, Kumar M, Ahmad T, et al. 2012. Antagonism of mmu-miR-106a attenuates asthma features in allergic murine model. J Appl Physiol (1985), 113, 459–464. doi: 10.1152/japplphysiol.00001.2012
  • Sharma A, Kumar M, Aich J, et al. 2009. Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a. Proc Natl Acad Sci USA, 106, 5761–5766. doi: 10.1073/pnas.0808743106
  • Shevach EM, Thornton AM. 2014. tTregs, pTregs, and iTregs: Similarities and differences. Immunol Rev, 259, 88–102. doi: 10.1111/imr.12160
  • Song B, Yan G, Hao H, Yang B. 2014. rs11671784 G/A and rs895819 A/G polymorphisms inversely affect gastric cancer susceptibility and miR-27a expression in a Chinese population. Med Sci Monit, 20, 2318–2326. doi: 10.12659/MSM.892499
  • Sonkoly E, Wei T, Janson PC, et al. 2007. MicroRNAs: Novel regulators involved in the pathogenesis of psoriasis? Plos One, 2, e610.
  • Sun G, Yan J, Noltner K, et al. 2009. SNPs in human miRNA genes affect biogenesis and function. RNA, 15, 1640–1651.
  • Takagi R, Higashi T, Hashimoto K, et al. 2008. B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clones. J Immunol, 181, 186–189.
  • Tan C, Gery I. 2012. The unique features of Th9 cells and their products. Crit Rev Immunol, 32, 1–10.
  • Wang Z, Liu M, Zhu H, et al. 2013. miR-106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS. Mol Carcinog, 52, 634–646. doi: 10.1002/mc.21899
  • Weetman AP. 2000. Chronic autoimmune thyroiditis. In The Thyroid: A Fundamental and Clinical Text, edited by Braverman LE, Utiger R, 721–732. Philadelphia: Lippincott Williams & Wilkins.
  • Xie N, Cui H, Banerjee S, et al. 2014. miR-27a regulates inflammatory response of macrophages by targeting IL-10. J Immunol, 193, 327–334. doi: 10.4049/jimmunol.1400203
  • Yang P, Foster CS. 2013. Interleukin 21, interleukin 23, and transforming growth factor beta1 in HLA-A29-associated birdshot retinochoroidopathy. Am J Ophthalmol, 156, 400–406 e2. doi: 10.1016/j.ajo.2013.03.004
  • Yang Y, Zhang K, Zhou R. 2014. Meta-analysis of pre-miRNA polymorphisms association with susceptibility to autoimmune diseases. Immunol Invest, 43, 13–27. doi: 10.3109/08820139.2013.822389

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.